Grufity logoGrufity logo
ScreenerStocksFundsSectorsWatchlists
CI

Cigna Corp

CI

257.85USD+0.36 (+0.14%)Market Closed
Watchlist

Market Summary

USD257.85+0.36
Market Closed
0.14%

CI Stock Price

View Fullscreen

CI RSI Chart

CI Valuation

Market Cap

91.1B

Price/Earnings (Trailing)

13.64

Price/Sales (Trailing)

1.92

EV/EBITDA

8.96

Price/Free Cashflow

8.41

CI Price/Sales (Trailing)

CI Profitability

EBT Margin

4.46%

Return on Equity

14.95%

Return on Assets

4.53%

Free Cashflow Yield

11.89%

CI Fundamentals

CI Revenue

Revenue (TTM)

189.9B

Revenue Y/Y

8.32%

Revenue Q/Q

0.95%

CI Earnings

Earnings (TTM)

6.8B

Earnings Y/Y

-3.82%

Earnings Q/Q

15.62%

Price Action

Last 7 days

-1.9%

Last 30 days

-12.6%

Last 90 days

-8.4%

Trailing 12 Months

-22.0%

How does CI drawdown profile look like?

CI Financial Health

Current Ratio

0.73

Debt/Equity

0.62

Debt/Cashflow

0.46

CI Investor Care

Dividend Yield

1.87%

Dividend/Share (TTM)

4.81

Diluted EPS (TTM)

17.7

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs
Net sales
YearQ1Q2Q3Q4
2023183.0B186.1B189.9B0
2022177.1B179.5B180.5B180.5B
2021162.9B166.8B170.1B174.1B
2020154.1B154.5B156.9B160.4B
201975.2B102.5B129.6B153.6B
201842.8B43.9B45.0B48.6B
201740.3B40.8B41.3B41.8B
201600039.8B

Latest Insider Trading transactions for CI

Filter Transactions
Datesorted ascendingNameBuy/Sell$ ValueAvg. Price# SharesTitle
Sep 14, 2023
eder noelle k
sold (taxes)
-257,359
285
-902
evp, technology & operations
Sep 01, 2023
brailer david j
sold (taxes)
-56,186
278
-202
evp & chief health officer
Aug 30, 2023
ryan cynthia
acquired
64,724
149
434
evp, chro
Aug 29, 2023
ryan cynthia
acquired
449,195
149
3,012
evp, chro
Aug 29, 2023
ryan cynthia
sold
-1,063,400
282
-3,768
evp, chro
Aug 21, 2023
jones nicole s
sold
-2,164,770
276
-7,819
evp, general counsel
Aug 08, 2023
agoglia hoeltzel mary t
sold
-3,564,750
291
-12,250
svp tax & chief acct. officer
Aug 08, 2023
agoglia hoeltzel mary t
acquired
351,158
78.035
4,500
svp tax & chief acct. officer
Aug 03, 2023
evanko brian c
acquired
44,479
78.035
570
evp, chief financial officer
Aug 02, 2023
evanko brian c
acquired
180,027
78.035
2,307
evp, chief financial officer

1–10 of 50

Which funds bought or sold CI recently?

View All Details
Datesorted ascendingFund NameType% Chg$ Change$ Held% Portfolio
Dec 06, 2023
CITIGROUP INC
reduced
-4.08
-1,601,130
70,994,100
0.05%
Dec 06, 2023
VisionPoint Advisory Group, LLC
added
112
16,000
29,749
0.01%
Dec 06, 2023
Fragasso Group Inc.
added
2.64
13,765
311,167
0.03%
Dec 06, 2023
Raleigh Capital Management Inc.
added
25.53
3,750
17,003
0.01%
Dec 05, 2023
Advisory Resource Group
added
2.34
134,678
3,241,760
0.88%
Dec 04, 2023
TUCKER ASSET MANAGEMENT LLC
unchanged
-
16.00
858
-%
Dec 01, 2023
PFS Partners, LLC
added
0.4
1,576
70,832
0.06%
Dec 01, 2023
B. Riley Wealth Advisors, Inc.
reduced
-60.15
-3,054,060
2,089,640
0.06%
Nov 30, 2023
Neo Ivy Capital Management
new
-
203,000
203,000
0.09%
Nov 30, 2023
Modera Wealth Management, LLC
added
13.86
73,898
533,521
0.01%

1–10 of 42

Latest Funds Activity

Are funds buying CI calls or puts?
Calls
Puts
No. of funds holding Calls - Puts
Net Call Options
No. of funds that own CI
No. of Funds

Schedule 13G FIlings of Cigna Corp

Date FiledName of FilerPercent of ClassNo. of SharesForm Type
Feb 14, 2023
dodge & cox
3.8%
11,548,557
SC 13G/A
Feb 14, 2023
price t rowe associates inc /md/
4.5%
13,656,608
SC 13G/A
Feb 09, 2023
fmr llc
-
0
SC 13G
Feb 09, 2023
vanguard group inc
8.37%
25,583,766
SC 13G/A
Feb 07, 2023
blackrock inc.
9.0%
27,469,496
SC 13G
Feb 14, 2022
dodge & cox
5.3%
17,484,197
SC 13G
Feb 14, 2022
price t rowe associates inc /md/
5.4%
17,961,332
SC 13G/A
Feb 09, 2022
vanguard group inc
7.88%
26,120,848
SC 13G/A
Feb 09, 2022
fmr llc
-
0
SC 13G/A
Feb 03, 2022
blackrock inc.
8.9%
29,587,276
SC 13G/A

Recent SEC filings of Cigna Corp

View All Filings
Date Filed Form Type Document
Dec 04, 2023
8-K
Current Report
Dec 04, 2023
4
Insider Trading
Dec 04, 2023
4
Insider Trading
Nov 02, 2023
8-K
Current Report
Nov 02, 2023
10-Q
Quarterly Report
Oct 13, 2023
144
Notice of Insider Sale Intent
Sep 18, 2023
4
Insider Trading
Sep 15, 2023
8-K
Current Report
Sep 11, 2023
8-K
Current Report
Sep 05, 2023
4
Insider Trading

Peers (Alternatives to Cigna Corp)

View All Peers In Detail
NameMkt Capsorted ascendingRevenuePrice %, 1MReturns, 1YP/EP/SRev 1-YrInc 1-Yr
LARGE-CAP
507.1B
360.0B
1.94% 1.34%
23.38
1.41
14.24% 11.62%
95.3B
347.8B
5.35% -27.64%
10.94
0.27
10.34% 159.11%
91.1B
189.9B
-12.60% -22.05%
13.64
1.92
5.24% 22.27%
68.3B
63.2B
8.96% 6.67%
11.95
1.08
5.62% 6.32%
39.7B
150.1B
3.44% -15.03%
16.23
0.26
6.04% 21.35%
MID-CAP
9.7B
11.9B
32.01% 41.29%
15.86
0.81
2.36% -10.41%
9.4B
14.0B
3.25% 4.87%
13.92
0.67
6.03% -8.61%
8.6B
2.2B
-1.50% 10.15%
35.21
3.87
4.50% -6.69%
6.6B
2.9B
-3.11% -12.16%
-359.29
2.29
13.16% -106.47%
2.6B
4.1B
9.38% -42.09%
9.26
0.63
-25.26% -41.25%
SMALL-CAP
1.6B
1.3B
13.24% 13.97%
34.75
1.17
27.06% -27.04%
1.4B
1.0B
6.69% -15.76%
25.11
1.41
10.84% 30.19%
982.6M
3.0B
18.37% 74.00%
-7.96
0.33
6.98% 58.07%
36.3M
-
2.22% -73.51%
-2.51
-
- -27.68%
15.3M
20.7M
7.02% -13.27%
52.66
0.74
6.53% -78.75%

Cigna Corp News

Latest updates
London South East01 Dec 202303:20 pm6 days ago
Nasdaq30 Nov 202311:56 am7 days ago
StreetInsider.com30 Nov 202301:35 am8 days ago
Investing.com Australia29 Nov 202309:45 pm8 days ago
Investing.com México29 Nov 202309:31 pm8 days ago
英为财情 Investing.com29 Nov 202309:30 pm8 days ago
Investing.com Россия29 Nov 202309:30 pm8 days ago
Investing.com India06 Nov 202308:00 am32 days ago
StockNews.com01 Nov 202307:00 am37 days ago
Reuters30 Sep 202307:00 am2 months ago
Finbold - Finance in Bold29 Sep 202307:00 am2 months ago
Finbold - Finance in Bold14 Sep 202307:00 am2 months ago
StockNews.com28 Aug 202307:00 am3 months ago
Reuters24 Aug 202307:00 am3 months ago

Financials for Cigna Corp

Income Statement (Last 12 Months)
(In Millions)
Income Statement (Quarterly)
(In Millions)
(*) denotes actual numbers (not divided by Millions)
Description(%) Q/Q2023Q32023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q42019Q32019Q22019Q12018Q42018Q3
Revenue1.0%49,04848,58646,51745,75245,28045,47844,00645,68844,28843,13140,97141,71240,95539,26538,46938,24538,55638,81937,94614,30011,457
  S&GA Expenses10.3%3,7883,4343,5383,4913,1483,2643,2753,6623,0932,9963,2793,9663,3013,4073,3983,9573,4133,3803,3033,4802,872
EBITDA Margin-100.0%-0.07*0.07*0.07*0.07*0.18*0.06*0.06*0.09*0.09*0.09*0.09*0.07*0.07*0.07*0.08*0.08*----
Interest Expenses24.8%38731032230630830730830331130833132736934839538839248837710040.00
Income Taxes4.5%3913742951297134113551794244223421,23640652920827740934841681.00259
Earnings Before Taxes-2.3%1,8401,8841,6011,3213,4911,9811,5671,3122,0591,8981,5135,3781,8042,2891,3971,2611,7631,7581,7882281,033
EBT Margin-100.0%-0.04*0.05*0.05*0.05*0.15*0.04*0.04*0.06*0.06*0.07*0.07*0.04*0.04*0.04*0.04*0.04*----
Net Income-100.0%-1,5101,3061,1922,7781,5701,2121,1331,6351,4761,1714,1421,3981,7601,1899771,3541,4101,372144772
Net Income Margin-100.0%-0.04*0.04*0.04*0.04*0.12*0.03*0.03*0.05*0.05*0.05*0.05*0.03*0.03*0.03*0.03*0.03*----
Free Cashflow-100.0%-2,4925,0282,0993,2831,2442,0304,2752,119-2967833,9845852,9641,5772,4832,218----
Balance Sheet
(In Millions)
Balance Sheet
(In Millions)
(*) denotes actual numbers (not divided by Millions)
Description(%) Q/Q2023Q32023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q42019Q32019Q22019Q12018Q42018Q3
Assets-0.3%149,645150,054147,976143,885144,209152,630152,610154,889154,251154,207152,081155,451160,044159,628154,711155,774154,847154,401154,348153,226130,359
  Current Assets-0.6%34,51834,71132,02730,12230,17037,42235,39336,13425,48725,01125,55427,79934,55734,88030,87729,84521,16820,70921,13620,430-
    Cash Equivalents-10.8%8,5469,5857,9355,9247,0794,4684,4695,0813,5403,8786,54410,2455,4067,1854,4524,6684,5773,6104,9763,85524,032
  Inventory-2.2%4,4164,5144,2114,7774,0173,7813,5003,7223,0203,0422,9193,1652,6572,7122,5652,6612,1602,2982,3822,821-
  Net PPE----------------4,4174,4484,5384,5234,562-
  Goodwill0.0%45,81045,81145,81145,81145,80745,81045,80445,81146,05646,06344,63544,64844,68544,59044,58444,60244,46244,44944,53744,505-
Liabilities-0.6%103,879104,528103,38099,13199,076106,663106,446107,705106,768105,440103,867105,065111,946112,223109,590110,395110,114110,552111,897112,15496,115
  Current Liabilities-0.6%47,05947,34544,72741,22541,11545,21843,66243,57236,34034,71133,47036,02243,88642,17940,38040,13834,44731,86732,96931,895-
  Long Term Debt-0.1%28,09428,11529,12428,10028,09030,98431,01331,12531,60931,60631,56829,54529,53731,77432,14731,89334,04136,88537,57139,523-
Shareholder's Equity0.6%45,70245,44544,51844,67545,04145,70146,14546,97647,42748,71648,15550,32848,03947,37145,08645,34444,69943,81842,41341,03515,555
  Retained Earnings2.6%40,98239,93638,84137,94037,04134,62633,42032,59331,80330,51329,38928,57524,44023,05221,29820,16219,18517,83416,42615,088-
  Additional Paid-In Capital0.4%30,56330,43630,33230,23329,39529,93029,73629,57429,07729,40329,25428,97528,77728,69928,55428,30628,11527,89127,85527,751-
Minority Interest-42.1%11.0019.0016.0013.0042.0030.0022.0018.0012.007.006.007.007.005.007.006.003.003.005.007.00-
Cashflow (Last 12 Months)
(In Millions)
Cashflow (Quarterly)
(In Millions)
(*) denotes actual numbers (not divided by Millions)
Description(%) Q/Q2023Q32023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q42019Q32019Q22019Q12018Q42018Q3
Cashflow From Operations13.4%2,8262,4925,0282,0993,2831,2442,0304,2752,119-2961,0934,2948953,2741,8872,7932,4611,0393,192126624
Cashflow From Investing-222.9%-1,337-414-2,983-6164,446-408-324123-710-2,307-7174,420-938-237-269-271-304-634475-24,704125
Cashflow From Financing-491.3%-2,572-435-37.00-2,636-5,517-916-2,171-2,371-1,728-62.00-4,051-4,721-1,682-312-1,818-1,707-1,173-1,773-2,5344,40019,657
  Dividend Payments0%362362368334341352357324330342345--15.00-------
  Buy Backs305.2%6241549621,7333,5001,0061,3681,4212,6119162,7941,6901,02836895644767440446232.00-

CI Income Statement

2023-09-30
Consolidated Statements of Income - USD ($)
$ in Millions
3 Months Ended9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
[1]
Sep. 30, 2023
Sep. 30, 2022
[1]
Revenues    
Premiums$ 10,998$ 9,586$ 33,062$ 30,368
Net investment income321204876943
TOTAL REVENUES49,04845,281144,151134,765
Benefits and expenses    
Pharmacy and other service costs33,63931,77798,54092,740
Medical costs and other benefit expenses8,9277,75127,00724,215
Selling, general and administrative expenses3,7883,15110,7609,690
Amortization of acquired intangible assets4544601,3681,419
TOTAL BENEFITS AND EXPENSES46,80843,139137,675128,064
Income from operations2,2402,1426,4766,701
Interest expense and other(365)(304)(1,086)(904)
(Loss) gain on sale of businesses(21)1,735(21)1,735
Net realized investment losses(14)(82)(44)(493)
Income before income taxes1,8403,4915,3257,039
TOTAL INCOME TAXES3917131,0601,479
Net income1,4492,7784,2655,560
Less: Net income attributable to noncontrolling interests412113049
SHAREHOLDERS' NET INCOME$ 1,408$ 2,757$ 4,135$ 5,511
Shareholders' net income per share    
Basic (in dollars per share)$ 4.79$ 9.07$ 14.03$ 17.64
Diluted (in dollars per share)$ 4.74$ 8.97$ 13.89$ 17.46
Pharmacy revenues    
Revenues    
Revenues$ 34,531$ 32,762$ 100,639$ 95,431
Fees and other revenues    
Revenues    
Revenues$ 3,198$ 2,729$ 9,574$ 8,023
[1]Amounts have been restated to reflect the adoption of Targeted Improvements to the Accounting for Long-Duration Contracts in 2023. See Note 2 to the Consolidated Financial Statements for further information.

CI Balance Sheet

2023-09-30
Consolidated Balance Sheets - USD ($)
$ in Millions
Sep. 30, 2023
Dec. 31, 2022
[1]
Assets  
Cash and cash equivalents$ 8,497$ 5,924
Investments1,046905
Accounts receivable, net19,08317,218
Inventories4,4164,777
Other current assets1,4761,298
Total current assets34,51830,122
Long-term investments18,97416,288
Reinsurance recoverables4,9205,416
Property and equipment3,9243,774
Goodwill45,81045,811
Other intangible assets31,32432,492
Other assets3,1472,704
Separate account assets7,0287,278
TOTAL ASSETS149,645143,885
Liabilities  
Current insurance and contractholder liabilities7,3525,409
Pharmacy and other service costs payable19,32017,070
Accounts payable7,6737,775
Accrued expenses and other liabilities9,6687,978
Short-term debt3,0462,993
Total current liabilities47,05941,225
Non-current insurance and contractholder liabilities11,28611,976
Deferred tax liabilities, net7,4807,786
Other non-current liabilities2,9322,766
Long-term debt28,09428,100
Separate account liabilities7,0287,278
TOTAL LIABILITIES103,87999,131
Contingencies — Note 16
Redeemable noncontrolling interests6466
Shareholders' equity  
Common stock[2]44
Additional paid-in capital30,56330,233
Accumulated other comprehensive loss(2,119)(1,658)
Retained earnings40,98237,940
Less: Treasury stock, at cost(23,739)(21,844)
TOTAL SHAREHOLDERS' EQUITY45,69144,675
Other noncontrolling interests1113
Total equity45,70244,688
Total liabilities and equity$ 149,645$ 143,885
[1]Amounts have been restated to reflect the adoption of Targeted Improvements to the Accounting for Long-Duration Contracts in 2023. See Note 2 to the Consolidated Financial Statements for further information.
[2]Par value per share, $0.01; shares issued, 399 million as of September 30, 2023 and 398 million as of December 31, 2022; authorized shares, 600 million.
CI
The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers. The company's Cigna Healthcare segment offers medical, pharmacy, behavioral health, dental, and other products and services for insured and self-insured customers; Medicare Advantage, Medicare Supplement, and Medicare Part D plans for seniors, as well as individual health insurance plans; and health care coverage in its international markets, as well as health care benefits for mobile individuals and employees of multinational organizations. The company also offers permanent insurance contracts sold to corporations to provide coverage on the lives of certain employees for financing employer-paid future benefit obligations. It distributes its products and services through insurance brokers and consultants; directly to employers, unions and other groups, or individuals; and private and public exchanges. The company was formerly known as Cigna Corporation and changed its name to The Cigna Group in February 2023. The Cigna Group was founded in 1792 and is headquartered in Bloomfield, Connecticut.
 CEO
 WEBSITEwww.cigna.com
 EMPLOYEES65535

Cigna Corp Frequently Asked Questions


What is the ticker symbol for Cigna Corp? What does CI stand for in stocks?

CI is the stock ticker symbol of Cigna Corp. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of Cigna Corp (CI)?

As of Thu Dec 07 2023, market cap of Cigna Corp is 91.1 Billion. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of CI stock?

You can check CI's fair value in chart. The fair value of Cigna Corp is provided for various growth and macro-economic scenarios from very pessimiatic to very optimistic assumptions. These fair values are estimates from Grufity's Fair Value model based on company's past performance. However, past performance of Cigna Corp is no guarantee of future performance. These fairvalue estimates should only be used as one of the inputs in your stock analysis. We provide model's historical fair value estimates for CI so that you know how good or bad the model has been in the past so you can discard it if needed. There are others that provide fair values of stocks such as wallmine, finbox, gurufocus and finviz. Most provide point in time estimates. We provide a history of our models fair value estimates so that you can get a sense of it's usefulness. Otherwise this data point is of little use.

Is Cigna Corp a good stock to buy?

The fair value guage provides a quick view whether CI is over valued or under valued. Whether Cigna Corp is cheap or expensive depends on the assumptions which impact Cigna Corp's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for CI.

What is Cigna Corp's Price to Earnings (PE) and Price to sales (PS) ratio?

As of Thu Dec 07 2023, CI's PE ratio (Price to Earnings) is 13.64 and Price to Sales (PS) ratio is 1.92. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. CI PE ratio will change depending on the future growth rate expectations of investors.

What is 5 year return on Cigna Corp's stock?

In the past 10 years, Cigna Corp has provided 0.119 (multiply by 100 for percentage) rate of return.